3-(4-piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists

被引：9

作者：

Crawforth, J ^{[1
]}

Goodacre, S ^{[1
]}

Maxey, R ^{[1
]}

Bourrain, S ^{[1
]}

Patel, S ^{[1
]}

Marwood, R ^{[1
]}

O'Connor, D ^{[1
]}

Herbert, R ^{[1
]}

Hutson, P ^{[1
]}

Rowley, M ^{[1
]}

机构：

[1] Merck Sharp & Dohme Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2000年 / 10卷 / 24期

关键词：

D O I：

10.1016/S0960-894X(00)00559-X

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of 3-(4-piperidinyl)- and 3-(8-aza-bicyclo[3.2.1] oct-3-yl)-2-phenyl-1H-indoles have been prepared and evaluated as ligands for the h5-HT2A receptor. 3-(8-Phenethyl-8-aza-bicyclol[3.2.1]oct-3-yl)-2-phenyl-1H-indole is a high-affinity (1.2 nM), selective (>800 fold over h5-HT2C and hD(2) receptors) antagonist at the h5-HT2A receptor with oral bioavailability in rats. (C) 2000 Elsevier Science Ltd. All rights reserved.

引用

页码：2701 / 2703

页数：3

共 50 条

[1] Discovery of N-substituted-endo-3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of μ-opioid receptor antagonists
Jiang, Lan
Beattie, David T.
Jacobsen, John R.
Kintz, Samuel
Obedencio, Glenmar P.
Saito, Daisuke
Stergiades, Ioanna
Vickery, Ross G.
Long, Daniel D.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (13) : 2926 - 2930
[2] 3-(4-piperidinyl)indoles and 3-(4-piperidinyl)pyrrolo-[2,3-b]pyridines as figands for the ORL-1 receptor
Bignan, Gilles C.
Battista, Kathleen
Connolly, Peter J.
Liu, Jingchun
Middleton, Steven A.
Reitz, Allen B.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (13) : 3524 - 3528
[3] 3-(4-fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT2A receptor antagonist
Rowley, M
Hallett, DJ
Goodacre, S
Moyes, C
Crawforth, J
Sparey, TJ
Patel, S
Marwood, R
Patel, S
Thomas, S
Hitzel, L
O'Connor, D
Szeto, N
Castro, JL
Hutson, PH
MacLeod, AM
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (10) : 1603 - 1614
[4] 3-[3-(4-bromophenyl)-1-phenyl-1H-pyrazol-4-yl]-5-ethoxy-2-phenyl-isoxazolidine
Etti, S.
Karthikeyan, K.
Shanmugam, G.
Perumal, P. T.
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O342 - U5703
[5] 3-[2-(pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: Agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype
Castro, JL
Street, LJ
Guiblin, AR
Jelley, RA
Russell, MGN
Sternfeld, F
Beer, MS
Stanton, JA
Matassa, VG
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (22) : 3497 - 3500
[6] 3-(5-Phenyl-2H-tetrazol-2-yl)pyridine
Ershov, Ivan S.
Esikov, Kirill A.
Nesterova, Olga M.
Skryl'nikova, Mariya A.
Khramchikhin, Andrey V.
Shmaneva, Nadezda T.
Chernov, Ivan S.
Chernova, Ekaterina N.
Puzyk, Aleksandra M.
Sivtsov, Eugene V.
Pavlyukova, Yuliya N.
Trifonov, Rostislav E.
Ostrovskii, Vladimir A.
MOLBANK, 2023, 2023 (01)
[7] Synthesis and Antitumor Activity of 3-(2-Phenyl-1,3-thiazol-4-yl)-1H-indoles and 3-(2-Phenyl-1,3-thiazol-4-yl)-1H-7-azaindoles
Diana, Patrizia
Carbone, Anna
Barraja, Paola
Montalbano, Alessandra
Parrino, Barbara
Lopergolo, Alessia
Pennati, Marzia
Zaffaroni, Nadia
Cirrincione, Girolamo
CHEMMEDCHEM, 2011, 6 (07) : 1300 - 1309
[8] SELECTIVE, CENTRALLY ACTING SEROTONIN 5-HT2 ANTAGONISTS .1. 2-SUBSTITUTED AND 6-SUBSTITUTED 1-PHENYL-3-(4-PIPERIDINYL)-1H-INDOLES
PERREGAARD, J
ANDERSEN, K
HYTTEL, J
SANCHEZ, C
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (26) : 4813 - 4822
[9] 3-(1H-Tetrazol-5-yl)pyridinium 3-(2H-tetrazol-5-yl)pyridinium dinitrate
Cui, Li-Jing
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : 01684 - U3360
[10] 3-[3-(Piperidin-1-yl)propyl] indoles as highly selective h5-HT1D receptor agonists
Russell, MGN
Matassa, VG
Pengilley, RR
van Niel, MB
Sohal, B
Watt, AP
Hitzel, L
Beer, MS
Stanton, JA
Broughton, HB
Castro, JL
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (24) : 4981 - 5001

← 1 2 3 4 5 →